Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Common Equity (2016 - 2022)

Sonoma Pharmaceuticals (SNOA) has 2 years of Common Equity data on record, last reported at $3.1 million in Q4 2012.

  • For Q4 2012, Common Equity rose 1819.02% year-over-year to $3.1 million; the TTM value through Dec 2012 reached $3.1 million, up 1819.02%, while the annual FY2012 figure was -$868000.0, 151.03% down from the prior year.
  • Common Equity reached $3.1 million in Q4 2012 per SNOA's latest filing, up from -$501000.0 in the prior quarter.
  • Across five years, Common Equity topped out at $3.1 million in Q4 2012 and bottomed at -$868000.0 in Q1 2012.